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Background: Samsoeum has long been used in Korea and other Asian countries as a traditional medicine to treat
various diseases. In the present study, we investigated the antiasthma effect of the herbal medicine Samsoeum
water extract (SSEW) using an in vivo ovalbumin (OVA)-induced asthmatic model.
Methods: Female BALB/c mice were sensitized by an intraperitoneal injection of OVA and subsequently challenged
with nebulized OVA. We investigated the number of inflammatory cells, the production of Th1/Th2 cytokines and
chemokine in bronchoalveolar lavage fluid (BALF), histological changes in lung tissue, the infiltration of inflammatory
cells and hyperplasia of goblet cells in lung tissue, the levels of immunoglobulin E (IgE) in BALF and plasma, and the
expression of inducible nitric oxide synthase (iNOS) in lung tissue.
Results: Our findings indicated that SSEW decreased the accumulation of inflammatory cells (particularly, eosinophil
and neutrophil) and regulated the balance in the production of Th1/Th2 cytokines and chemokine in BALF. Moreover,
SSEW suppressed the level of IgE in BALF and plasma, and inhibited the infiltration of inflammatory cells, hyperplasia of
goblet cells, and the expression of iNOS in lung tissue.
Conclusions: Collectively, these results suggest that, because of its anti-inflammatory and antiasthma properties, SSEW
may be useful in reducing airway inflammation in the treatment of allergic asthma.
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Allergic asthma is a chronic inflammatory disease of the
airway that is characterized by airway inflammation, in-
tense eosinophilia, lymphocyte infiltration, and mucus
overproduction [1]. Allergen-specific CD4+ T cells play a
pivotal role in the development of asthma [2]. Th1 cells
allergies are caused by characteristic immunoresponses
to allergens, primarily mediated by Th2 cells. Th2 cells
synthesize high levels of interleukin 4 (IL-4), IL-5, and
IL-13, which leads to the release of allergen-specific im-
munoglobulin E (IgE) and the production of mediators
from mast cells [3]. It has largely been aceepted that an* Correspondence: cozy11@kiom.re.kr
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ical expression of this allergic disease [4]. Spina et al. re-
ported that the pathophysiology of asthma is related to a
Th1/Th2 cell imbalance in the airways [5]. Because
asthma is associated with decreased Th2 responses, en-
hanced Th1 responses may suppress the development of
allergic airway inflammation.
Lung inflammation in allergic asthma is induced by a
cascade of reactions involving several mediators, inclu-
ding nitric oxide (NO). NO plays an essential role in
regulating airway function and in the pathophysiology of
inflammatory airway diseases. NO is synthesized from
L-arginine by NO synthase (NOS), which exists in three
isoforms: neuronal NOS (nNOS: NOS-1), endothelial
NOS (eNOS: NOS-3), and inducible NOS (iNOS: NOS-2).
It is now known that each of these isoforms may behis is an Open Access article distributed under the terms of the Creative
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ever, iNOS is induced after exposure to proinflammatory
cytokines and is expressed in epithelial and inflammatory
cells of the airway [7]. Several studies have suggested that
the downregulation of iNOS expression inhibits airway in-
flammation in an asthmatic model [8,9].
Traditional herbal medicines are composed of various
components. These components exhibit various thera-
peutic effects; thus, mixed herbal medicines are applied
to multiple diseases [10]. Samsoeum (known as Shen-su-
yin in Chinese) is composed of 12 different crude com-
ponents obtained from natural herbs. It is one of the
major traditional herbal medicines that are used widely
in the treatment of headache, fever, cough and rhinor-
rhea caused by cold wind. According to previous studies,
Samsoeum has immunomodulating [11] and antiallergic
effects [12]. However, there is little information on
the mechanism underlying the antiasthmatic effect of
Samsoeum. In particular, the inhibitory mechanism of
Samsoeum on airway inflammation remains unclear.
Therefore, we examined the protective effects of a
Samsoeum water extract (SSEW) on the airway inflam-
mation induced by ovalbumin (OVA) challenge.
Methods
Preparation of the SSEW
A voucher specimen of Samsoeum (2008-KE28) is avail-
able at the Herbal Medicine Formulation Research Group,
Korea Institute of Oriental Medicine. Samsoeum was
prepared in our laboratory from a mixture of chopped
crude herbs that were purchased from Omniherb (Korea;
Geochang, Jecheon, Geumsan, Yeongcheon, and Jeju)
and HMAX (China). Professor Je-Hyun Lee of Dongguk
University, Gyeongju, Republic of Korea, confirmed theTable 1 Crude components of Samsoeum
Scientific name Amount (g)
Perillae Herba 3.75 (9.1%)
Puerariae Radix 3.75 (9.1%)
Pinelliae Tuber 3.75 (9.1%)
Anthrisci Radix 3.75 (9.1%)
Ginseng Radix 3.75 (9.1%)
Poria Sclerotium 3.75 (9.1%)
Aurantii Fructus 2.8125 (6.8%)
Platycodonis Radix 2.8125 (6.8%)
Glycyrrhizae Radix 2.8125 (6.8%)
Citri Unshius Pericarpium 2.8125 (6.8%)
Zingiberis Rhizoma 3.75 (9.1%)
Zizyphi Fructus 3.75 (9.1%)
Total amount 41.25 (100%)identity of each crude herb. A decoction of Samsoeum
was prepared using a mixture of herbal medicines accord-
ing to composition in the laboratory (Table 1). The herbal
medicines of Samsoeum were extracted in distilled water
at 100°C for 2 h. The extract solution was evaporated to
dryness and then frozen to a dry powder (yield, 18.6%).
Animals
Specific pathogen-free female BALB/c mice (6 weeks of
age) were purchased from Orient Co. (Seoul, Korea) and
used after 1 week of quarantine and acclimatization.
Mice were maintained in an animal facility under stan-
dard laboratory conditions for 1 week prior to experi-
ments, and were provided with water and standard chow
ad libitum. All experimental procedures were performed
in compliance with the NIH guidelines for the Care and
Use of Laboratory Animals and were approved by Korea
Institute of Oriental Medicine Institutional Animal Care
and Use Committee (Approval number: #10-011). The
animal handling followed the dictates of the National
Animal Welfare Law of Korea.
OVA-induced allergic asthma
The mice were randomly divided into 5 groups (n = 6 per
group): NC (normal control group, PBS sensitization/
challenge), OVA (OVA sensitization/challenge), Mon (OVA
sensitization/challenge + oral gavage of 30 mg/kg of mon-
telukast), SSEW-100 (OVA sensitization/challenge + oral
gavage of 100 mg/kg of SSEW), and SSEW-200 (OVA
sensitization/challenge + oral gavage of 200 mg/kg of
SSEW).
OVA sensitization and airway challenge were per-
formed as described previously [13]. Briefly, mice were
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droxide in 200 μL of PBS buffer (pH 7.4). On days 21,
22, and 23 after the initial sensitization, mice received an
airway challenge with OVA (1%, w/v, in PBS) for 1 h
using an ultrasonic nebulizer (NE-U12; Omron Corp.,
Tokyo, Japan). SSEW was dissolved in PBS and was pre-
pared fresh daily before each treatment. SSEW was ad-
ministered by gavage to mice at doses of 100 mg/kg or
200 mg/kg once daily from days 18 to 23. Normal- and
positive-control mice were administered PBS or Mon
(30 mg/kg in PBS) orally, respectively. Mon was de-
veloped as a cysteinyl leukotriene (cys-LT)-1 receptor
antagonist [14] and was introduced into the market after
successful clinical evaluation in patients with aspirin-
sensitive asthma, nocturnal exacerbation of asthma, and
allergic asthma [15].
After the OVA challenge, bronchoalveolar lavage fluid
(BALF) samples were obtained from the mice and proc-
essed, and inflammatory cells were counted as described
previously [13]. Briefly, mice were sacrificed by intrape-
ritoneal injection of pentobarbital (50 mg/kg; Hanlim
Pharm. Co., Seoul, Korea) 48 h after the last challenge,
and tracheostomy was performed. A schematic diagram
of the treatment schedule is shown in Figure 1. To ob-
tain BALF, ice-cold PBS (0.5 mL) was infused into the
lung and withdrawn via tracheal cannulation three times
(total volume, 1.5 mL). The number of total inflamma-
tory cells was assessed by counting cells in at least five
squares of a hemocytometer after exclusion of dead cells
by Trypan blue staining. To determine differential cell
counts, 100 μL of BALF was centrifuged onto slides
using a cytospin machine (Hanil Science Industrial,
Seoul, Korea) (200 g, 4°C, 10 min). The slides were dried
and the cells were fixed and stained using the Diff-Quik®
staining reagent (B4132-1A; IMEB Inc., Deerfield, IL),
according to the manufacturer’s instructions. The super-
natant obtained from BALF was stored at −70°C for bio-
chemical analysis.Figure 1 Asthmatic mouse model: airway inflammation and treatmenMeasurement of the levels of Th1/Th2 cytokines,
chemokines, and IgE
The levels of TNF-α, eotaxin, IL-4, IL-5, IL-10, IL-13, and
IL-33 in BALF were measured using enzyme-linked im-
munosorbent assay (ELISA) kits (BioSource International,
Camarillo, CA) according to the manufacturer’s protocols.
The detection range of IL-13 is 3.9 pg/mL to 250 pg/mL,
and IL-5 is 7.8 pg/mL to 500 pg/mL. The detection ranges
of TNF-α and IL-4 are 15.6 pg/mL to 1000 pg/mL, and
eotaxin, IL-10 and IL-33 are 31.25 pg/mL to 2000 pg/mL.
The levels of total IgE and OVA-Specific in BALF and
plasma were measured using ELISA. Microtiter plates
were coated with anti-IgE antibodies (anti-mouse IgE;
10 g/mL; Serotec, Oxford, UK) in PBS-Tween 20, and in-
cubated with BALF or plasma. The plates were then
washed four times, and 200 μL of O-phenylenediamine
dihydrochloride (Sigma-Aldrich, St. Louis, MO) was
added to each well. The plates were incubated for 10 min
in the dark and the absorbance was then measured at
450 nm.
Lung tissue histopathology
After BALF samples were obtained, lung tissue was fixed
in 10% (v/v) neutral-buffered formalin. Tissues were em-
bedded in paraffin, sectioned at a 4 μm thickness, and
stained with hematoxylin and eosin stain (H&E) solution
(hematoxylin, Sigma MHS-16, and eosin, Sigma HT110-
1-32) and periodic acid–Schiff (PAS) (IMEB Inc., San
Marcos, CA) to estimate inflammatory cell accumulation
and mucus production, respectively. Quantitative analysis
for airway inflammation and mucus secretion was eva-
luated using a MetaMorph Offline version 7.7.0.0 image
analysis software (Molecular Devices Inc., Sunnyvale, CA,
USA).
Western blotting
Equal amounts of total lung protein (30 μg) were heated
at 100°C for 5 min, loaded onto 8% sodium dodecylsulfatet with SSEW.
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trophoresed. The proteins were then transferred to a
nitrocellulose membrane (at 100 V for 2 h). The mem-
brane was blocked for 1 h with Tris-buffered saline
containing 0.05% Tween-20 (TBST) plus 5% skim milk,
followed by incubation with anti-iNOS (sc-7271,
1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz,
CA) and anti-β-actin (#4967S, 1:1000 dilution; Cell
Signaling Technology, Danvers, MA) antibodies over-
night at 4°C. The embrane was washed three times
with TBST at intervals of 10 min and then incubated
with a horseradish peroxidase (HRP)-conjugated se-
condary antibody (iNOS: anti-mouse, β-actin: anti-
rabbit 1:3000 dilution; Jackson ImmunoResearch, West
Grove, PA) for 1 h at room temperature. The membrane
was washed three times with TBST at intervals of
10 min and developed using an enhanced chemilu-
minescence kit (ECL; Amersham Pharmacia Biotech,
Uppsala, Sweden). Then, membrane were photographed
and for quantitative analysis, densitometric band values
were determined using commercially available ChemiDoc™
XRS+ imaging system (Bio-Rad Laboratories, Hercules,
CA, USA).Statistical analyses
Data are expressed as means ± standard error of the mean
(SEM). Statistical significance was determined using ana-
lysis of variance (ANOVA) followed by a multiple com-
parison test with Bonferroni adjustment. P values < 0.05
or < 0.01 were considered significant.Figure 2 Effect of SSEW on inflammatory cell accumulation in the BA
challenge, and the cells were isolated by cytospin and stained with Diff-Qu
(control); Mon, montelukast (30 mg/kg) + OVA-induced group (positive con
SSEW (200 mg/kg) + OVA-induced group. The values represent the mean ±
the NC group. Significant differences at *P < 0.05 and **P < 0.01 comparedResults
SSEW reduced the number of inflammatory cells in BALF
To measure inflammatory cells, we counted the number
of total cells, lymphocyte, neutrophils, macrophages, and
eosinophils in BALF. The levels of inflammatory cells in
BALF were significantly elevated in the OVA group
compared with the NC group. However, SSEW treat-
ment (100 and 200 mg/kg) markedly reduced the num-
ber of total cells, neutrophil and eosinophils than in the
Mon group, which was a positive-control drug in this
study (Figure 2).SSEW decreased the Th1 cytokine and Th2 chemokine
levels in BALF
To investigate the effects of SSEW on the T-cell im-
mune response in asthmatic mice, we evaluated the
production of Th1-type cytokines and the Th2-type
chemokines in BALF. As shown in Figure 3A, the level
of TNF-α was significantly decreased in the OVA group
compared with the NC group. However, the Mon group
exhibited a significantly increased level of TNF-α com-
pared with the OVA group, and the level of TNF-α
increased gradually in the SSEW groups (100 and
200 mg/kg) compared with the OVA group in a dose-
dependent manner. In contrast, the level of eotaxin was
significantly increased in the OVA group compared
with the NC group. Finally, the administration of Mon
and SSEW (100 and 200 mg/kg) significantly inhibited
the level of eotaxin compared with what was observed
in the OVA group (Figure 3B).LF of OVA-induced mice. BALF was collected 48 h after the last OVA
ick. NC, normal control group (vehicle); OVA, OVA-induced group
trol); SSEW-100, SSEW (100 mg/kg) + OVA-induced group; SSEW-200,
S.E.M (n = 6/group). Significant differences at ##P < 0.01 compared with
with the OVA-induced group.
Figure 3 Effect of SSEW on Th1 cytokines and Th2 chemokine the in BALF of OVA-induced mice. Individual data were obtained using
ELISA. (A) TNF-α and (B) eotaxin levels. NC, normal control group (vehicle); OVA, OVA-induced group (control); Mon, montelukast (30 mg/kg) +
OVA-induced group (positive control); SSEW-100, SSEW (100 mg/kg) + OVA-induced group; SSEW-200, SSEW (200 mg/kg) + OVA-induced group.
The values represent the mean ± S.E.M (n = 6/group). Significant differences at ##P < 0.01 compared with the NC group. Significant differences at
*P < 0.05 and **P < 0.01 compared with the OVA-induced group.
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To confirm the association between SSEW and Th2 re-
sponses in BALF from OVA-induced asthmatic mice, we
assessed the levels of Th2-type cytokines in BALF.
Figure 4 shows that the OVA group exhibited signifi-
cantly elevated levels of Th2-type cytokines, including
(A) IL-4, (B) IL-5, (C) IL-10, (D) IL-13, and (E) IL-33,
compared with the NC group. However, the SSEW
groups (100 and 200 mg/kg) showed significantly de-
creased levels of Th2 cytokines compared with the OVA
group, similar to the Mon group (Figure 4A–E).
SSEW improved histopathological changes in lung tissue
To analyze the effects of SSEW on the histological fea-
tures of asthma, we performed H&E and PAS staining in
lung tissues of OVA-induced asthmatic mice. OVA-
induced lung tissues were characterized by peribronchial
and perivascular inflammation caused by leukocyte infil-
tration compared with normal lung tissues; most infil-
trating inflammatory cells were eosinophils. However,
treatment with SSEW (100 and 200 mg/kg) markedly de-
creased eosinophil-rich leukocyte infiltration compared
with the OVA group (Figure 5A,C). Mucus overproduc-
tion caused by goblet cell hyperplasia is characteristic of
airway obstruction and airway remodeling. In the OVA
group, mucus overproduction was clearly observed as a
violet color in lung tissues compared with the NC group.
However, administration of SSEW (100 and 200 mg/kg)
markedly attenuated the mucus overproduction compared
with the OVA group (Figure 5B,D).
SSEW reduced the release of IgE levels in plasma and
BALF
Because Th2-type cytokines promote airway inflamma-
tion in asthma via the increase in IgE levels, we evalua-
ted the levels of IgE in plasma and BALF. As shown in
Table 2, the levels of IgE were significantly increased in
the OVA group (total IgE in BALF, 3.52 ± 0.36 ng/mL;total IgE and OVA-specific IgE in plasma, 1073.31 ±
123.77 and 54.57 ± 11.88; P < 0.01) compared with those
observed in the NC group. However, SSEW treatment sig-
nificantly inhibited the levels of total IgE (SSEW-100 and
SSEW-200 in BALF, 2.73 ± 0.59 and 2.56 ± 0.37 ng/mL;
SSEW-100 and SSEW-200 in plasma, 793.52 ± 83.49 and
771.48 ± 68.52 ng/mL) and OVA-specific IgE (SSEW-100
and SSEW-200 in plasma, 32.84 ± 15.23 and 45.35 ±
7.67 ng/mL) compared with the OVA group.
SSEW inhibited the expression of iNOS in lung tissue
To assess the association between the expression of the
iNOS protein and bronchial asthma, we evaluated iNOS
expression by western blotting. iNOS was markedly
upregulated in the OVA group compared with the NC
group. SSEW treatment (100 and 200 mg/kg) suppressed
the upregulation of iNOS in a dose-dependent manner
(Figure 6).
Discussion
In the present study, we investigated the anti-inflammatory
and anti-asthmatic effects of SSEW in an OVA-induced
murine asthma model. OVA-induced mice showed an in-
creased number of inflammatory cells, elevated IgE pro-
duction, imbalance of Th1/Th2 cytokines and chemokines
in BALF, mucus hypersecretion, eosinophil-rich leukocyte
infiltration, and increased expression of iNOS in lung tis-
sues. However, SSEW treatment increased the level of a
Th1 cytokine (TNF-α) and decreased the levels of Th2 cy-
tokines (IL-4, IL-5, IL-10, IL-13, and IL-33) and of a
chemokine (eotaxin), IgE production, and the number of
inflammatory cells (particularly, eosinophils and neutro-
phil) in BALF. The administration of SSEW also inhibited
mucus overproduction, leukocyte infiltration, and expres-
sion of iNOS in lung tissues. First, we demonstrated that
SSEW decreased the expression of iNOS in this model.
In traditional herbal medicine, herb mixtures are con-
sidered to produce a synergistic effect and a reduction of
Figure 4 Effect of SSEW on Th2 cytokines in the BALF of OVA-induced mice. Individual data were obtained using ELISA. (A) IL-4, (B) IL-5,
(C) IL-10, (D) IL-13, and (E) IL-33. NC, normal control group (vehicle); OVA, OVA-induced group (control); Mon, montelukast (30 mg/kg) + OVA-induced
group (positive control); SSEW-100, SSEW (100 mg/kg) + OVA-induced group; SSEW-200, SSEW (200 mg/kg) + OVA-induced group. The values represent
the mean ± S.E.M (n = 6/group). Significant differences at ##P < 0.01 compared with the NC group. Significant differences at *P < 0.05 and **P < 0.01
compared with the OVA-induced group.
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[16]. SSEW is a water extract that consists of Perillae
Herba, Puerariae Radix, Pinelliae Tuber, Anthrisci Radix,
Ginseng Radix, Poria Sclerotium, Aurantii Fructus,
Platycodonis Radix, Glycyrrhizae Radix, Citri Unshius
Pericarpium, Zingiberis Rhizoma, and Zizyphi Fructus
(Table 1). Among these herbs, earlier studies reported
that Perillae Herba, Pinelliae Tuber and PlatycodonisRadix have antiasthmatic effects [17-19]; Puerariae
Radix, Poria Sclerotium, and Aurantii Fructus have the
anti-inflammatory effects [20-22]; Glycyrrhizae Radix,
Zingiberis Rhizoma, and Zizyphi Fructus have antioxidant
effects [23-25]; Anthrisci Radix and Citri Unshius Pericar-
pium have antiobesity effects [26,27]; and Ginseng Radix
has an immunomodulating effect [28]. Accordingly, we
predicted that SSEW, which is a mixture of these herbs,
Figure 5 Effect of SSEW on airway inflammation and airway goblet cell hyperplasia in the lung tissues of OVA-induced mice. Lung
tissues were stained with (A) H&E solution and (B) PAS. The panel is magnified (200 ×). Representative photomicrographs of lung sections are
shown. Yellow arrows indicated as airway inflammation and mucus production. (C) Inflammation and (D) mucus production index were determined using
an image analyzer, respectively. NC, normal control group (vehicle); OVA, OVA-induced group (control); Mon, montelukast (30 mg/kg) +OVA-induced group
(positive control); SSEW-100, SSEW (100 mg/kg) + OVA-induced group; SSEW-200, SSEW (200 mg/kg) + OVA-induced group. The values represent the
mean ± S.E.M (n = 3/group). Significant differences at ##P < 0.01 compared with the NC group. Significant differences at **P < 0.01 compared with the
OVA-induced group.
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matic and anti-inflammatory effects, on OVA-induced air-
way inflammation in a murine asthma model.
The infiltration of eosinophils into the airways is a
characteristic of asthma, and increased numbers of these
cells have been found in BALF. The proinflammatorymediators derived from eosinophils are major contribu-
tors to the inflammation observed in asthma, which in-
cludes airway epithelial cell loss and damage, airway
dysfunction, and mucus hypersecretion [29]. Our results
demonstrated that the administration of SSEW signifi-
cantly reduced the number of eosinophil-rich leukocytes
Table 2 Effect of SSEW on IgE levels in BALF and plasma
Groups BALF Plasma
Total IgE (ng/mL) Total IgE (ng/mL) OVA-specific IgE (ng/mL)
NC 1.95 ± 10.63 262.95 ± 107.60 < 0
OVA 3.52 ± 0.36## 1073.31 ± 123.77## 54.57 ± 11.88##
Mon 2.24 ± 0.50** 636.29 ± 102.28** 33.32 ± 10.35**
SSEW-100 2.73 ± 0.59* 793.52 ± 83.49** 32.84 ± 15.23*
SSEW-200 2.56 ± 0.37** 771.48 ± 68.52** 45.35 ± 7.67
NC, normal control group (vehicle); OVA, OVA-induced group (control); Mon, montelukast (30 mg/kg) + OVA-induced group (positive control); SSEW-100, SSEW
(100 mg/kg) + OVA-induced group; SSEW-200, SSEW (200 mg/kg) + OVA-induced group. The values represent the mean ± S.E.M. (n = 6 in each group). Significant
differences at ##P < 0.01 compared with the NC group. Significant differences at *P < 0.05 and **P < 0.01 compared with the OVA-induced group.
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of lung tissues paralleled the results of the analysis of
the cell count in BALF. In support of these results,
histopathological findings revealed that SSEW treatment
markedly attenuated the number of infiltrated inflamma-
tory cells and mucus hyperproduction of goblet cells in
lung tissues. Eosinophils regulate the allergen-dependent
Th2 immune responses mediated by dendritic cells and
T lymphocytes and attenuate Th1 responses [30]. Hence,
the imbalance of Th1/Th2 cell responses plays anFigure 6 Effect of SSEW on iNOS expression in lung tissues of OVA-in
expression was determined using western blot analysis. (A) Expression of iN
expression (normalized to β-actin) were quantified. NC, normal control gro
(30 mg/kg) + OVA-induced group (positive control); SSEW-100, SSEW (100 mg
group. The values represent the mean ± S.E.M (n = 3/group). Significant differe
*P < 0.05 compared with the OVA-induced group.important part in the development of asthma, and in-
duces different immune responses and immunologically
dysregulated states. Th1 cells produce proinflammatory
cytokines; among them, TNF-α is a potent multifunc-
tional cytokine and a chemoattractant for neutrophils
and eosinophils [31]. In our experiments, SSEW treat-
ment significantly increased the reduced levels of TNF-α
by OVA induction. Th2 cells play an important role in
the initiation and progression of allergic diseases, inclu-
ding asthma. Th2 cytokines (IL-4, IL-5, IL-10, IL-13, andduced mice. Lung tissues were homogenized and iNOS protein
OS in the lung tissue. (B) Relative ratio: The relative levels of iNOS
up (vehicle); OVA, OVA-induced group (control); Mon, montelukast
/kg) + OVA-induced group; SSEW-200, SSEW (200 mg/kg) + OVA-induced
nces at ##P < 0.01 compared with the NC group. Significant differences at
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matory responses, such as infiltration of inflammatory
cells, eosinophil activation, IgE production, and mucus
hypersecretion [32]. Our findings indicate that SSEW
administration significantly decreased the increased
Th2-type cytokines and chemokine production. Several
studies have shown that modulation of Th1/Th2 cytokines
can inhibit airway inflammation in OVA-induced mice
[33,34]. Therefore, these findings suggest that SSEW at-
tenuates airway inflammation through the modulation of
the Th1/Th2 balance.
IgE, which is a key target for the development of anti-
asthma strategies, is one of the most important factors
in the progression of allergic reactions. Previous studies
have indicated that anti-IgE treatment may be effective
in allergic diseases [13,35]. In our study, SSEW treat-
ment significantly reduced the increase in the levels of
IgE (total IgE and OVA-specific IgE) that was related to
the development of allergic reactions. These results sug-
gest that SSEW is an effective agent in the treatment of
allergic asthma.
Excessive NO contributes to the pathogenesis of air-
way inflammation, cellular injury, and tissue damage in
the lung. iNOS caused by NO production is well known
for its potential role in inducing airway diseases, inclu-
ding asthma. iNOS production is increased in asthmatic
lung tissues and several types of inflammatory cells [36].
Previous studies have shown that iNOS expression is
closely related to the recruitment of inflammatory cells
in airways, including eosinophils and neutrophils [9]. In
the present study, the expression of the iNOS protein
was intensely increased in lung tissues of OVA-induced
mice. In contrast, SSEW markedly decreased the overex-
pression of iNOS induced by OVA in a dose-dependent
manner. These findings indicate that SSEW may atte-
nuate the infiltration of inflammatory cells via the
downregulation of iNOS expression. Taken together, our
results suggest that SSEW exerts potent antiasthmatic
and anti-inflammatory effects by suppressing proinflam-
matory cytokines and mediators related to eosinophils.
Conclusion
In summary, our results suggest that SSEW plays a pivotal
role in OVA-induced airway inflammation by reducing
the number of inflammatory cells (particularly, eosinophil
and neutrophil), inflammatory cells infiltration, IgE levels,
mucus production, and iNOS protein expression, and
modulating Th1/Th2 cytokines. These findings suggest
that SSEW has the potential to alleviate airway inflamma-
tion in the treatment of allergic asthma because of its anti-
asthma and anti-inflammatory properties.
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